PANACEA LIFE SCIENCES HOLDINGS, INC. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q2 2021 to Q1 2024.
  • Panacea Life Sciences Holdings, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2024 was $1.06M, a 55.9% increase year-over-year.
  • Panacea Life Sciences Holdings, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending March 31, 2024 was $2.76M, a 50.4% increase year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $2.38M, a 46.6% increase from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $1.63M, a 21% decline from 2021.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.76M $1.06M +$379K +55.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $2.38M $960K +$636K +196% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.75M $348K -$18.4K -5.02% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.77M $399K -$70.3K -15% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-15
Q1 2023 $1.84M $677K +$211K +45.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.63M $325K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $366K -$222K -37.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $469K +$156K +49.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 $466K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $588K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $313K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.